Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Verrica Pharmaceuticals Inc. (VRCA)
USD5.68
-0.25 (-4.22%)
US NASDAQ Healthcare Biotechnology
Address
44 West Gay Street Suite 400 19380
West Chester, PA, US
West Chester, PA, US
CEO
Jayson Rieger
Website
verrica.com
IPO
2018-06-15
CIK 1660334 ISIN US92511W2070
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.68
-0.25 (-4.22%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
71.6K
Beta
1.49
Float Shares
6.78M
Free Float %
63.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.38% | -14.06% | +39.92% | +28.60% | +87.17% | -13.96% | +41.30% | -88.37% | -93.76% | -95.91% | -95.91% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
5.68
Low
17.00
+199.3%
Consensus
17.00
+199.3%
Median
17.00
+199.3%
High
17.00
+199.3%
Ratings Trend (MoM)
80% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
17.00
+199.3%
|
| All Time | 4 |
13.25
+133.3%
|
Quality scores
Altman Z-Score
-9.76
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+370.2% ★ Q1'26: +46.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+88.6% ★ Q1'26: +56.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-70.7% Q1'26: -182.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-33.6% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+105.6% Q1'26: +124.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.15× Q1'26: -0.04× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 1 EPS Ana. |
Dec 2028 3 Rev. Ana. 2 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
12.00M
est: 12.00M (+0.0%)
|
9.03M
est: 7.42M (+21.8%)
|
5.12M
est: 8.91M (-42.5%)
|
7.57M
est: 8.25M (-8.3%)
|
35.58M
est: 35.00M (+1.6%)
|
24.83M
16.82M – 31.65M
-29.1% YoY
|
45.35M
21.20M – 66.20M
+82.7% YoY
|
92.60M
62.74M – 118.05M
+104.2% YoY
|
158.20M
107.19M – 201.68M
+70.8% YoY
|
207.65M
140.69M – 264.72M
+31.3% YoY
|
| EBITDA |
-30.31M
est: -7.20M (-321.0%)
|
-21.60M
est: -4.45M (-385.4%)
|
-62.20M
est: -7.69M (-708.9%)
|
-65.90M
est: -7.12M (-825.3%)
|
-11.16M
est: -30.20M (+63.0%)
|
-21.42M
-27.31M – -14.51M
+29.1% YoY
|
-39.12M
-57.11M – -18.29M
-82.7% YoY
|
-79.89M
-101.84M – -54.13M
-104.2% YoY
|
-136.48M
-173.99M – -92.47M
-70.8% YoY
|
-179.15M
-228.38M – -121.38M
-31.3% YoY
|
| EBIT |
-30.79M
est: -7.20M (-327.6%)
|
-22.32M
est: -4.45M (-401.5%)
|
-63.03M
est: -7.73M (-715.6%)
|
-67.17M
est: -7.16M (-838.4%)
|
-11.94M
est: -30.35M (+60.7%)
|
-21.53M
-27.45M – -14.59M
+29.1% YoY
|
-39.32M
-57.40M – -18.38M
-82.7% YoY
|
-80.29M
-102.36M – -54.40M
-104.2% YoY
|
-137.18M
-174.88M – -92.94M
-70.8% YoY
|
-180.06M
-229.54M – -122.00M
-31.3% YoY
|
| Net Income |
-35.08M
est: -75.38M (+53.5%)
|
-24.49M
est: -47.37M (+48.3%)
|
-67.00M
est: -18.04M (-271.4%)
|
-76.58M
est: -153.51M (+50.1%)
|
-17.89M
est: -17.89M (+0.0%)
|
-14.91M
-20.88M – -8.93M
+16.7% YoY
|
-7.71M
-10.80M – -4.62M
+48.3% YoY
|
4.85M
213.0K – 9.48M
+162.9% YoY
|
15.23M
8.85M – 20.68M
+214.3% YoY
|
19.81M
11.51M – 26.89M
+30.1% YoY
|
| SGA |
26.98M
est: 53.24M (-49.3%)
|
17.41M
est: 32.90M (-47.1%)
|
47.31M
est: 39.52M (+19.7%)
|
58.82M
est: 36.60M (+60.7%)
|
35.22M
est: 155.20M (-77.3%)
|
110.10M
74.60M – 140.35M
-29.1% YoY
|
201.10M
94.01M – 293.55M
+82.7% YoY
|
410.62M
278.22M – 523.47M
+104.2% YoY
|
701.52M
475.31M – 894.31M
+70.8% YoY
|
920.80M
623.88M – 1.17B
+31.3% YoY
|
| EPS |
-12.97
est: -14.55 (+10.9%)
|
-7.17
est: -9.14 (+21.6%)
|
-14.78
est: -1.75 (-745.9%)
|
-14.78
est: -14.46 (-2.2%)
|
-1.68
est: -1.26 (-33.6%)
|
-1.44
-1.96 – -0.84
-14.8% YoY
|
-0.75
-1.01 – -0.43
+48.3% YoY
|
0.46
0.02 – 0.89
+160.9% YoY
|
1.43
0.83 – 1.94
+214.3% YoY
|
1.86
1.08 – 2.52
+30.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-7.11M
OE per share TTM
-0.71
Owner's Yield
-9.02%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
37.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
5
Total invested
116.4K
Insider transactions (90d)
0
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Paul B. Manning | 15.39M | 37.40% | 13.91M | 1.48M | 13.91M | 1.48M | IN | United States | 2022-07-15 | ↗ |
| 2 | B. Manning | 9.84M | 38.00% | 8.36M | 1.48M | 8.36M | 1.48M | IN | — | 2021-02-16 | ↗ |
| 3 | Avoro Capital Advisors LLC | 6.58M | 9.99% | 6.58M | — | 6.58M | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 4 | Behzad Aghazadeh | 6.58M | 9.99% | 6.58M | — | 6.58M | — | IN | United States | 2024-02-14 | ↗ |
| 5 | Joseph Edelman | 3.61M | 13.10% | — | 3.61M | — | 3.61M | IN | Delaware | 2022-02-14 | ↗ |
| 6 | Perceptive Advisors LLC | 3.61M | 13.10% | — | 3.61M | — | 3.61M | IA | Delaware | 2022-02-14 | ↗ |
| 7 | Perceptive Life Sciences Master Fund, Ltd. | 3.61M | 13.10% | — | 3.61M | — | 3.61M | CO | Delaware | 2022-02-14 | ↗ |
| 8 | 10 | 3.41M | 13.30% | — | 3.41M | — | 3.41M | IA | Delaware | 2019-02-14 | ↗ |
| 9 | 13.3% | 3.41M | 13.30% | — | 3.41M | — | 3.41M | CO | Delaware | 2019-02-14 | ↗ |
| 10 | Matt Davidson | 2.47M | 9.60% | 2.47M | — | 2.47M | — | IN | — | 2020-01-30 | ↗ |
| 11 | Growth Investments, LLC | 1.48M | 5.70% | 1.48M | — | 1.48M | — | OO | — | 2021-02-16 | ↗ |
| 12 | BKB Growth Investments, LLC | 1.48M | 3.60% | 1.48M | — | 1.48M | — | OO | Delaware | 2022-07-15 | ↗ |
| 13 | NAME OF REPORTING | 1.48M | 5.76% | — | 1.48M | — | 1.48M | OO | Delaware | 2018-06-25 | ↗ |
| 14 | Davidson | 1.45M | 5.60% | 1.45M | — | 1.45M | — | IN | — | 2021-01-25 | ↗ |
| 15 | Page 2 of 5 Pages | 560.7K | 2.04% | 560.7K | — | 560.7K | — | IN | — | 2022-01-27 | ↗ |
| 16 | Capital Investments, LLC | 256.6K | 1.00% | 256.6K | — | 256.6K | — | OO | — | 2021-02-16 | ↗ |
| 17 | PBM Capital Investments, LLC | 256.6K | 0.60% | 256.6K | — | 256.6K | — | OO | Delaware | 2022-07-15 | ↗ |
| 18 | OrbiMed Advisors LLC | — | 0.00% | — | — | — | — | IA | Delaware | 2022-02-11 | ↗ |
| 19 | OrbiMed Capital LLC | — | 0.00% | — | — | — | — | IA | Delaware | 2022-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
5
-44 vs prev Q
New positions
0
Closed positions
44
Increased
1
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 235.8K +235.8K (+100.0%) | 1.96B +2.0B (+100.0%) | 2.48% +2.485 pp | 1.94% +1.938 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 2 | ARMISTICE CAPITAL, LLC | 1.12M +479.7K (+75.1%) | 9.30M +6.5M (+237.5%) | 11.79% +5.055 pp | 0.11% +0.070 pp | USD6.02 +38.0% | 2 qtrs — |
| 3 | CALIGAN PARTNERS LP | 923.9K +— (+0.0%) | 7.68M +3.7M (+92.8%) | 9.74% +0.000 pp | 0.63% +0.111 pp | USD4.31 +92.8% | 2 qtrs — |
| 4 | AFFINITY ASSET ADVISORS, LLC | 707.3K +707.3K (+100.0%) | 5.88M +5.9M (+100.0%) | 7.45% +7.453 pp | 0.33% +0.335 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 5 | VELAN CAPITAL INVESTMENT MANAGEMENT LP | 471.6K +471.6K (+100.0%) | 3.92M +3.9M (+100.0%) | 4.97% +4.969 pp | 2.27% +2.273 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 6 | STONEPINE CAPITAL MANAGEMENT, LLC | 353.7K +353.7K (+100.0%) | 2.94M +2.9M (+100.0%) | 3.73% +3.727 pp | 2.15% +2.146 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 280.7K +— (+0.0%) | 2.33M +1.1M (+92.8%) | 2.96% +0.000 pp | 0.03% +0.017 pp | USD4.31 +92.8% | 2 qtrs — |
| 8 | DAFNA CAPITAL MANAGEMENT LLC | 173.5K +173.5K (+100.0%) | 1.44M +1.4M (+100.0%) | 1.83% +1.828 pp | 0.33% +0.335 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 9 | VANGUARD GROUP INC | 138.2K -87.0K (-38.6%) | 1.15M +177.7K (+18.3%) | 1.46% -0.917 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 10 | TWO SIGMA INVESTMENTS, LP | 118.2K +118.2K (+100.0%) | 982.4K +982.4K (+100.0%) | 1.25% +1.246 pp | 0.00% +0.001 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 11 | JANE STREET GROUP, LLC | 101.7K +101.7K (+100.0%) | 845.3K +845.3K (+100.0%) | 1.07% +1.072 pp | 0.00% +0.000 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 12 | MARSHALL WACE, LLP | 85.2K +85.2K (+100.0%) | 707.8K +707.8K (+100.0%) | 0.90% +0.898 pp | 0.00% +0.001 pp | USD8.31 +0.0% | 3 qtrs — |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 67.7K +— (+0.0%) | 562.4K +270.7K (+92.8%) | 0.71% +0.000 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 14 | TWO SIGMA ADVISERS, LP | 44.4K +44.4K (+100.0%) | 369.2K +369.2K (+100.0%) | 0.47% +0.468 pp | 0.00% +0.001 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 15 | SQUAREPOINT OPS LLC | 33.3K +33.3K (+100.0%) | 276.5K +276.5K (+100.0%) | 0.35% +0.351 pp | 0.00% +0.000 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 16 | SOVRAN ADVISORS, LLC | 32.7K -41.1K (-55.8%) | 248.5K -12.0K (-4.6%) | 0.34% -0.434 pp | 0.02% -0.002 pp | USD4.31 +92.8% | 2 qtrs — |
| 17 | RENAISSANCE TECHNOLOGIES LLC | 26.4K -2.8K (-9.6%) | 219.4K +93.6K (+74.4%) | 0.28% -0.029 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 18 | MARINER, LLC | 24.5K -6.0 (0.0%) | 204.0K +98.2K (+92.8%) | 0.26% 0.000 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 19 | STATE STREET CORP | 23.5K +2.9K (+14.1%) | 195.1K +106.4K (+120.0%) | 0.25% +0.031 pp | 0.00% +0.000 pp | USD4.80 +73.1% | 2 qtrs — |
| 20 | MILLENNIUM MANAGEMENT LLC | 23.1K -48.9K (-67.9%) | 192.2K -118.1K (-38.1%) | 0.24% -0.515 pp | 0.00% 0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 21 | OMERS ADMINISTRATION CORP | 22.6K +22.6K (+100.0%) | 187.8K +187.8K (+100.0%) | 0.24% +0.238 pp | 0.00% +0.001 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 22 | MORGAN STANLEY | 22.0K +321.0 (+1.5%) | 182.9K +89.4K (+95.7%) | 0.23% +0.003 pp | 0.00% +0.000 pp | USD4.37 +90.2% | 2 qtrs — |
| 23 | NORTHERN TRUST CORP | 20.0K -7.0 (0.0%) | 166.4K +80.1K (+92.7%) | 0.21% 0.000 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 24 | GOLDMAN SACHS GROUP INC | 18.6K +18.6K (+100.0%) | 154.7K +154.7K (+100.0%) | 0.20% +0.196 pp | 0.00% +0.000 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 25 | HRT FINANCIAL LP | 17.4K +17.4K (+100.0%) | 144.0K +144.0K (+100.0%) | 0.18% +0.183 pp | 0.00% +0.001 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 26 | LEGACY TRUST | 17.2K +17.2K (+100.0%) | 143.2K +143.2K (+100.0%) | 0.18% +0.182 pp | 0.03% +0.027 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 27 | WALLEYE CAPITAL LLC | 15.2K +15.2K (+100.0%) | 126.6K +126.6K (+100.0%) | 0.16% +0.161 pp | 0.00% +0.000 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 28 | XTX TOPCO LTD | 14.7K +14.7K (+100.0%) | 121.8K +121.8K (+100.0%) | 0.15% +0.155 pp | 0.00% +0.003 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 29 | BECK MACK & OLIVER LLC | 12.0K +12.0K (+100.0%) | 99.7K +99.7K (+100.0%) | 0.13% +0.126 pp | 0.00% +0.002 pp | USD8.31 +0.0% | 3 qtrs — |
| 30 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12.0K +— (+0.0%) | 99.7K +48.0K (+92.8%) | 0.13% +0.000 pp | 0.00% +0.001 pp | USD4.31 +92.8% | 2 qtrs — |
| 31 | QUADRATURE CAPITAL LTD | 12.0K +12.0K (+100.0%) | 99.3K +99.3K (+100.0%) | 0.13% +0.126 pp | 0.00% +0.001 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 32 | MAN GROUP PLC | 11.3K +11.3K (+100.0%) | 93.8K +93.8K (+100.0%) | 0.12% +0.119 pp | 0.00% +0.000 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 33 | BLACKROCK, INC. | 5.7K -463.0 (-7.5%) | 47.2K +20.7K (+78.3%) | 0.06% -0.005 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 34 | BANK OF AMERICA CORP /DE/ | 4.3K +4.3K (+5,931.9%) | 36.1K +35.8K (+11,541.9%) | 0.05% +0.045 pp | 0.00% +0.000 pp | USD8.24 +0.8% | 2 qtrs — |
| 35 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.3K +1.8K (+116.6%) | 27.8K +21.1K (+317.6%) | 0.04% +0.019 pp | 0.00% +0.001 pp | USD6.46 +28.6% | 2 qtrs — |
| 36 | CAPITAL ANALYSTS, LLC | 1.5K +— (+0.0%) | 12.0K +6.0K (+100.0%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 37 | FORTITUDE FAMILY OFFICE, LLC | 608.00 +608.0 (+100.0%) | 5.1K +5.1K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.001 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 38 | ROYAL BANK OF CANADA | 416.00 -793.0 (-65.6%) | 3.0K -2.0K (-40.0%) | 0.00% -0.008 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 39 | SALOMON & LUDWIN, LLC | 290.00 +— (+0.0%) | 2.6K +1.2K (+90.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 40 | NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 200.00 +— (+0.0%) | 1.7K +800.0 (+92.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.31 +92.8% | 2 qtrs — |
| 41 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 175.00 +175.0 (+100.0%) | 1.5K +1.5K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD8.31 +0.0% | 1 qtrs NEW |
| 42 | BNP PARIBAS ARBITRAGE, SNC | 110.00 -14.0 (-11.3%) | 914.00 +380.0 (+71.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD4.30 +93.3% | 2 qtrs — |
| 43 | PNC FINANCIAL SERVICES GROUP, INC. | 102.00 +— (+0.0%) | 847.00 +408.0 (+92.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.30 +93.3% | 2 qtrs — |
| 44 | JPMORGAN CHASE & CO | 47.00 +47.0 (+100.0%) | 391.00 +391.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD8.30 +0.1% | 1 qtrs NEW |
| 45 | OPTIVER HOLDING B.V. | 31.00 +— (+0.0%) | 258.00 +124.0 (+92.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.29 +93.7% | 2 qtrs — |
| 46 | UBS GROUP AG | 24.00 -41.6K (-99.9%) | 199.00 -179.2K (-99.9%) | 0.00% -0.438 pp | 0.00% +0.000 pp | USD4.29 +93.7% | 2 qtrs — |
| 47 | GROUP ONE TRADING, L.P. | 3.00 +— (+0.0%) | 25.00 +12.0 (+92.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.00 +107.8% | 2 qtrs — |
| 48 | MAI CAPITAL MANAGEMENT | 2.00 +— (+0.0%) | 17.00 +8.0 (+88.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.00 +107.8% | 2 qtrs — |
| 49 | FMR LLC | — -3.3K (-100.0%) | — -14.4K (-100.0%) | 0.00% -0.035 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 50 | NISA INVESTMENT ADVISORS, LLC | — -142.0 (-100.0%) | — -612.0 (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 51 | SRS CAPITAL ADVISORS, INC. | — -9.0 (-100.0%) | — -38.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 52 | CITIGROUP INC | — -2.1K (-100.0%) | — -8.9K (-100.0%) | 0.00% -0.022 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 53 | ADVISOR GROUP HOLDINGS, INC. | — -568.0 (-100.0%) | — -301.0 (-100.0%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD— | 10 qtrs SOLD |
| 54 | BARCLAYS PLC | — -31.3K (-100.0%) | — -45.4K (-100.0%) | 0.00% -0.330 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 17 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 210.5K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 762.7K | 0.05% |
| 3 | Avantis Total Equity Markets ETF 1 AVTM | 0.00% | 3.0K | 0.23% |
| 4 | Dimensional - US Core Equity 1 ETF DCOR | 0.00% | 10.8K | 0.14% |
| 5 | Dimensional - US Small Cap ETF DFAS | 0.00% | 48.2K | 0.26% |
| 6 | U.S. Micro Cap Portfolio ETF DFMC | 0.00% | 13.9K | 0.43% |
| 7 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 1.5K | 0.03% |
| 8 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 303.40 | 0.17% |
| 9 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 4.1K | 0.17% |
| 10 | Vanguard Total Stock Market ETF VTI | 0.00% | 702.0K | 0.03% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
12
Sells
0
Shares acquired
5.30M
Shares disposed
—
Cash buys
12.00
Cash sales
—
Net activity
+5,295,431
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-26 | Frantzreb Charles | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-26 | Caligan Partners LP | Other | — | — | Common Stock, par value $0.0001 per share ("Common Stock") | 0 | 0.00 | — | 923,910 | I | ↗ |
| 2025-12-23 | Kirby John J. | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 18,962 | D | ↗ |
| 2025-11-25 | Zawitz David | Officer | P-Purchase | A | Series C Warrant (right to buy) | 2,500 | 6.32 | 15.8K | 2,500 | D | ↗ |
| 2025-11-25 | Rosenberg Noah L. | Officer | P-Purchase | A | Series C Warrant (right to buy) | 589 | 6.32 | 3.7K | 589 | D | ↗ |
| 2025-11-25 | Rieger Jayson | Director / Officer | P-Purchase | A | Series C Warrant (right to buy) | 23,577 | 6.32 | 148.9K | 23,577 | D | ↗ |
| 2025-11-25 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Series C Warrant (right to buy) | 687,690 | 6.32 | 4.34M | 687,690 | I | ↗ |
| 2025-11-25 | Kirby John J. | Officer | P-Purchase | A | Common Stock | 3,536 | 4.24 | 15.0K | 8,962 | D | ↗ |
| 2025-11-25 | Caligan Partners LP | Other | — | — | Series C Warrants (right to buy) | 1,031,559 | 6.32 | 6.51M | 0 | I | ↗ |
| 2025-11-25 | BKB Growth Investments, LLC | 10% Owner | — | — | Series B Warrants (right to buy) | 224,719 | 13.35 | 3.00M | 0 | D | ↗ |
| 2025-06-05 | PRYGOCKI MARK A SR | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.58 | 11.6K | 20,000 | D | ↗ |
| 2025-06-05 | Nguyen Diem | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.58 | 11.6K | 20,000 | D | ↗ |
| 2025-06-05 | Eichenfield Lawrence | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.58 | 11.6K | 20,000 | D | ↗ |
| 2025-06-05 | Corcoran Gavin | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.58 | 11.6K | 20,000 | D | ↗ |
| 2025-03-31 | Corcoran Gavin | Director | — | — | Common Stock | 0 | 0.00 | — | 20 | D | ↗ |
| 2025-03-24 | Rosenberg Noah L. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-17 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 4,315 | 0.65 | 2.8K | 176,458 | D | ↗ |
| 2025-03-14 | Rieger Jayson | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 850,000 | 0.89 | 756.5K | 850,000 | D | ↗ |
| 2025-03-14 | Hayes Christopher G. | Officer | A-Award | A | Employee Stock Option (right to buy) | 250,000 | 0.89 | 222.5K | 250,000 | D | ↗ |
| 2024-12-09 | Zawitz David | Officer | A-Award | A | Employee Stock Option (right to buy) | 950,000 | 0.95 | 902.5K | 950,000 | D | ↗ |
| 2024-11-26 | Stalfort John A III | Director | G-Gift | A | Common Stock | 50,000 | 0.00 | — | 1,873,800 | D | ↗ |
| 2024-11-26 | Rieger Jayson | Director / Officer | G-Gift | A | Common Stock | 50,000 | 0.00 | — | 882,826 | D | ↗ |
| 2024-11-26 | Manning Paul B | Director / 10% Owner | G-Gift | D | Common Stock | 450,000 | 0.00 | — | 25,828,094 | D | ↗ |
| 2024-11-22 | Stalfort John A III | Director | P-Purchase | A | Series B Warrants (right to buy) | 561,797 | 1.34 | 750.0K | 561,797 | D | ↗ |
| 2024-11-22 | Rieger Jayson | Director / Officer | P-Purchase | A | Series A Warrants (right to buy) | 140,449 | 1.07 | 150.0K | 140,449 | D | ↗ |
| 2024-11-22 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Series A Warrants (right to buy) | 2,247,191 | 1.07 | 2.40M | 2,247,191 | I | ↗ |
| 2024-11-22 | Caligan Partners LP | Other | — | — | Series B Warrants (right to buy) | 421,346 | 13.35 | 5.62M | 0 | I | ↗ |
| 2024-11-06 | Rieger Jayson | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 2,000,000 | 0.75 | 1.49M | 2,000,000 | D | ↗ |
| 2024-11-06 | Kirby John J. | Officer | A-Award | A | Common Stock | 54,267 | 0.00 | — | 54,267 | D | ↗ |
| 2024-11-05 | Rieger Jayson | Director / Officer | — | — | Common Stock | 0 | 0.00 | — | 551,928 | D | ↗ |
| 2024-11-05 | Kirby John J. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-09 | Hayes Christopher G. | Officer | A-Award | A | Employee Stock Option (right to buy) | 50,000 | 1.28 | 64.0K | 50,000 | D | ↗ |
| 2024-09-19 | Manning Paul B | Director / 10% Owner | G-Gift | D | Common Stock | 2,675,611 | 0.00 | — | 0 | I | ↗ |
| 2024-08-27 | White Ted | Director / Officer | S-Sale | D | Common Stock | 9,021 | 2.46 | 22.2K | 215,967 | — | ↗ |
| 2024-08-27 | Kohler Terry | Officer | S-Sale | D | Common Stock | 7,899 | 2.46 | 19.4K | 44,697 | — | ↗ |
| 2024-08-27 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 9,530 | 2.46 | 23.4K | 105,773 | — | ↗ |
| 2024-08-27 | Goldenberg Gary | Officer | S-Sale | D | Common Stock | 3,601 | 2.46 | 8.9K | 94,261 | — | ↗ |
| 2024-08-27 | Bonaccorso Joe | Officer | S-Sale | D | Common Stock | 8,993 | 2.46 | 22.1K | 73,114 | — | ↗ |
| 2024-08-26 | White Ted | Director / Officer | S-Sale | D | Common Stock | 24,979 | 2.66 | 66.4K | 224,988 | — | ↗ |
| 2024-08-26 | Kohler Terry | Officer | S-Sale | D | Common Stock | 21,820 | 2.66 | 58.0K | 52,596 | — | ↗ |
| 2024-08-26 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 26,183 | 2.66 | 69.6K | 115,303 | — | ↗ |
| 2024-08-26 | Goldenberg Gary | Officer | S-Sale | D | Common Stock | 9,888 | 2.66 | 26.3K | 97,862 | — | ↗ |
| 2024-08-26 | Bonaccorso Joe | Officer | S-Sale | D | Common Stock | 24,709 | 2.66 | 65.7K | 82,107 | — | ↗ |
| 2024-07-23 | White Ted | Director / Officer | S-Sale | D | Common Stock | 154 | 6.98 | 1.1K | 249,967 | — | ↗ |
| 2024-07-23 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 91 | 6.98 | 635.18 | 141,486 | — | ↗ |
| 2024-07-23 | Goldenberg Gary | Officer | S-Sale | D | Common Stock | 86 | 6.98 | 600.28 | 107,750 | — | ↗ |
| 2024-07-23 | Bonaccorso Joe | Officer | S-Sale | D | Common Stock | 115 | 6.98 | 802.70 | 106,816 | — | ↗ |
| 2024-07-22 | White Ted | Director / Officer | S-Sale | D | Common Stock | 32,469 | 7.06 | 229.2K | 250,121 | — | ↗ |
| 2024-07-22 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 21,649 | 7.06 | 152.8K | 141,577 | — | ↗ |
| 2024-07-22 | Goldenberg Gary | Officer | S-Sale | D | Common Stock | 18,421 | 7.06 | 130.1K | 107,836 | — | ↗ |
| 2024-07-22 | Bonaccorso Joe | Officer | S-Sale | D | Common Stock | 25,461 | 7.06 | 179.8K | 106,931 | — | ↗ |
| 2024-06-06 | PRYGOCKI MARK A SR | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 8.78 | 175.6K | 20,000 | — | ↗ |
| 2024-06-06 | Nguyen Diem | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 8.78 | 175.6K | 20,000 | — | ↗ |
| 2024-06-06 | Eichenfield Lawrence | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 8.78 | 175.6K | 20,000 | — | ↗ |
| 2024-06-06 | Ballaron Craig | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 8.78 | 175.6K | 20,000 | — | ↗ |
| 2024-03-15 | White Ted | Director / Officer | A-Award | A | Common Stock | 112,500 | 0.00 | — | 282,590 | — | ↗ |
| 2024-03-15 | Kohler Terry | Officer | A-Award | A | Employee Stock Option (right to buy) | 80,000 | 4.80 | 384.0K | 80,000 | — | ↗ |
| 2024-03-15 | Hayes Christopher G. | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 163,226 | — | ↗ |
| 2024-03-15 | Goldenberg Gary | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 126,257 | — | ↗ |
| 2024-03-15 | Bonaccorso Joe | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 132,392 | — | ↗ |
| 2023-12-29 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 115,774 | 7.24 | 838.2K | 7,099,182 | — | ↗ |
| 2023-12-28 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 126,116 | 7.08 | 892.9K | 6,983,408 | — | ↗ |
| 2023-12-27 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 79,726 | 7.20 | 574.0K | 6,857,292 | — | ↗ |
| 2023-12-26 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 54,652 | 6.49 | 354.7K | 6,777,566 | — | ↗ |
| 2023-12-22 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 250,000 | 6.67 | 1.67M | 6,722,914 | — | ↗ |
| 2023-12-21 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 6.17 | 1.23M | 6,472,914 | — | ↗ |
| 2023-12-19 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 277,008 | 5.36 | 1.48M | 6,272,914 | — | ↗ |
| 2023-12-18 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 456,923 | 5.41 | 2.47M | 5,995,906 | — | ↗ |
| 2023-12-15 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 500,000 | 5.97 | 2.99M | 5,538,983 | — | ↗ |
| 2023-11-15 | White Ted | Director / Officer | S-Sale | D | Common Stock | 11,558 | 2.97 | 34.3K | 170,090 | — | ↗ |
| 2023-11-15 | Kohler Terry | Officer | S-Sale | D | Common Stock | 9,632 | 2.97 | 28.6K | 34,416 | — | ↗ |
| 2023-11-15 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 11,558 | 2.97 | 34.3K | 123,226 | — | ↗ |
| 2023-11-15 | Goldenberg Gary | Officer | S-Sale | D | Common Stock | 3,036 | 2.97 | 9.0K | 86,257 | — | ↗ |
| 2023-11-15 | Bonaccorso Joe | Officer | S-Sale | D | Common Stock | 11,266 | 2.97 | 33.5K | 92,392 | — | ↗ |
| 2023-11-14 | White Ted | Director / Officer | S-Sale | D | Common Stock | 22,141 | 2.93 | 64.9K | 181,648 | — | ↗ |
| 2023-11-14 | Kohler Terry | Officer | S-Sale | D | Common Stock | 18,452 | 2.93 | 54.1K | 44,048 | — | ↗ |
| 2023-11-14 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 22,141 | 2.93 | 64.9K | 134,784 | — | ↗ |
| 2023-11-14 | Goldenberg Gary | Officer | S-Sale | D | Common Stock | 5,817 | 2.93 | 17.0K | 89,293 | — | ↗ |
| 2023-11-14 | Bonaccorso Joe | Officer | S-Sale | D | Common Stock | 21,580 | 2.93 | 63.2K | 103,658 | — | ↗ |
| 2023-08-24 | White Ted | Director / Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 203,789 | — | ↗ |
| 2023-08-24 | Kohler Terry | Officer | A-Award | A | Common Stock | 62,500 | 0.00 | — | 62,500 | — | ↗ |
| 2023-08-24 | Hayes Christopher G. | Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 156,925 | — | ↗ |
| 2023-08-24 | Goldenberg Gary | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 95,110 | — | ↗ |
| 2023-08-24 | Bonaccorso Joe | Officer | A-Award | A | Common Stock | 125,000 | 0.00 | — | 187,738 | D | ↗ |
| 2023-07-24 | White Ted | Director / Officer | S-Sale | D | Common Stock | 50,677 | 4.83 | 244.8K | 128,789 | — | ↗ |
| 2023-07-24 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 200,000 | 5.02 | 1.00M | 7,851,128 | — | ↗ |
| 2023-07-24 | Hayes Christopher G. | Officer | S-Sale | D | Common Stock | 33,789 | 4.83 | 163.2K | 81,925 | — | ↗ |
| 2023-07-24 | Goldenberg Gary | Officer | S-Sale | D | Common Stock | 28,699 | 4.83 | 138.6K | 70,110 | — | ↗ |
| 2023-07-24 | Bonaccorso Joe | Officer | S-Sale | D | Common Stock | 38,262 | 4.83 | 184.8K | 62,738 | — | ↗ |
| 2023-07-21 | White Ted | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 179,466 | — | ↗ |
| 2023-07-21 | Hayes Christopher G. | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 115,714 | — | ↗ |
| 2023-07-21 | Goldenberg Gary | Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 98,809 | — | ↗ |
| 2023-07-21 | Bonaccorso Joe | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 101,000 | — | ↗ |
| 2023-06-08 | PRYGOCKI MARK A SR | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 5.70 | 59.2K | 10,384 | — | ↗ |
| 2023-06-08 | Nguyen Diem | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 5.70 | 59.2K | 10,384 | — | ↗ |
| 2023-06-08 | Eichenfield Lawrence | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 5.70 | 59.2K | 10,384 | — | ↗ |
| 2023-06-08 | Ballaron Craig | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 5.70 | 59.2K | 10,384 | — | ↗ |
| 2023-03-01 | White Ted | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 240,000 | 7.58 | 1.82M | 240,000 | — | ↗ |
| 2023-03-01 | Kohler Terry | Officer | A-Award | A | Employee Stock Option (right to buy) | 85,000 | 7.58 | 644.3K | 85,000 | — | ↗ |
| 2023-03-01 | Hayes Christopher G. | Officer | A-Award | A | Employee Stock Option (right to buy) | 135,000 | 7.58 | 1.02M | 135,000 | — | ↗ |
| 2023-03-01 | Goldenberg Gary | Officer | A-Award | A | Employee Stock Option (right to buy) | 85,000 | 7.58 | 644.3K | 85,000 | — | ↗ |
| 2023-03-01 | Bonaccorso Joe | Officer | A-Award | A | Employee Stock Option (right to buy) | 85,000 | 7.58 | 644.3K | 85,000 | — | ↗ |
| 2022-07-11 | Hayes Christopher G. | Officer | P-Purchase | A | Common Stock | 7,500 | 3.40 | 25.5K | 15,714 | — | ↗ |
| 2022-07-05 | White Ted | Director / Officer | P-Purchase | A | Common Stock | 7,500 | 2.10 | 15.8K | 29,466 | — | ↗ |
| 2022-07-05 | Stalfort John A III | Director | P-Purchase | A | Common Stock | 238,095 | 2.10 | 500.0K | 700,205 | — | ↗ |
| 2022-07-05 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 1,428,571 | 2.10 | 3.00M | 5,038,983 | — | ↗ |
| 2022-07-05 | Manning Paul B | Director | P-Purchase | A | Common Stock | 4,761,904 | 2.10 | 10.00M | 13,651,128 | — | ↗ |
| 2022-07-05 | Hayes Christopher G. | Officer | P-Purchase | A | Common Stock | 5,714 | 2.10 | 12.0K | 8,214 | — | ↗ |
| 2022-07-05 | Goldenberg Gary | Officer | P-Purchase | A | Common Stock | 23,809 | 2.10 | 50.0K | 23,809 | — | ↗ |
| 2022-07-05 | EDELMAN JOSEPH | Director | P-Purchase | A | Common Stock | 1,428,571 | 2.10 | 3.00M | 5,038,983 | — | ↗ |
| 2022-06-09 | PRYGOCKI MARK A SR | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 0.00 | — | 10,384 | — | ↗ |
| 2022-06-09 | Nguyen Diem | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 2.15 | 22.3K | 10,384 | — | ↗ |
| 2022-06-09 | Eichenfield Lawrence | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 0.00 | — | 10,384 | — | ↗ |
| 2022-06-09 | Ballaron Craig | Director | A-Award | A | Stock Option (right to buy) | 10,384 | 0.00 | — | 10,384 | — | ↗ |
| 2022-02-24 | White Ted | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 200,000 | 8.00 | 1.60M | 200,000 | — | ↗ |
| 2022-02-24 | Kohler Terry | Officer | A-Award | A | Employee Stock Option (right to buy) | 75,000 | 8.00 | 600.0K | 75,000 | — | ↗ |
| 2022-02-24 | Hayes Christopher G. | Officer | A-Award | A | Employee Stock Option (right to buy) | 75,000 | 8.00 | 600.0K | 75,000 | — | ↗ |
| 2022-02-24 | Goldenberg Gary | Officer | A-Award | A | Employee Stock Option (right to buy) | 75,000 | 8.00 | 600.0K | 75,000 | — | ↗ |
| 2022-02-24 | Bonaccorso Joe | Officer | A-Award | A | Employee Stock Option (right to buy) | 75,000 | 8.00 | 600.0K | 75,000 | — | ↗ |
| 2021-12-31 | Manning Paul B | Director / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-03 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 19,977 | 9.22 | 184.2K | 8,149,394 | — | ↗ |
| 2021-12-02 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 30,023 | 9.45 | 283.7K | 8,129,417 | — | ↗ |
| 2021-07-16 | Kohler Terry | Officer | A-Award | A | Employee Stock Option (right to buy) | 125,000 | 10.28 | 1.29M | 125,000 | — | ↗ |
| 2021-06-10 | PRYGOCKI MARK A SR | Director | A-Award | A | Stock Option (right to buy) | 5,834 | 10.56 | 61.6K | 5,834 | — | ↗ |
| 2021-06-10 | Nguyen Diem | Director | A-Award | A | Stock Option (right to buy) | 5,834 | 10.56 | 61.6K | 5,834 | — | ↗ |
| 2021-06-10 | Eichenfield Lawrence | Director | A-Award | A | Stock Option (right to buy) | 5,834 | 10.56 | 61.6K | 5,834 | — | ↗ |
| 2021-06-10 | Ballaron Craig | Director | A-Award | A | Stock Option (right to buy) | 5,834 | 10.56 | 61.6K | 5,834 | — | ↗ |
| 2021-06-04 | White Ted | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 9.95 | 39.8K | 21,966 | — | ↗ |
| 2021-06-04 | Hayes Christopher G. | Officer | P-Purchase | A | Common Stock | 2,500 | 9.79 | 24.5K | 2,500 | — | ↗ |
| 2021-06-04 | DAVIS A BRIAN | Officer | P-Purchase | A | Common Stock | 5,000 | 9.89 | 49.5K | 12,900 | — | ↗ |
| 2021-03-25 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 739,830 | 14.75 | 10.91M | 739,830 | — | ↗ |
| 2021-03-01 | White Ted | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 160,000 | 14.32 | 2.29M | 160,000 | — | ↗ |
| 2021-03-01 | Hayes Christopher G. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 65,000 | 14.32 | 930.8K | 65,000 | — | ↗ |
| 2021-03-01 | Goldenberg Gary | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 65,000 | 14.32 | 930.8K | 65,000 | — | ↗ |
| 2021-03-01 | DAVIS A BRIAN | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 65,000 | 14.32 | 930.8K | 65,000 | — | ↗ |
| 2021-03-01 | Bonaccorso Joe | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 65,000 | 14.32 | 930.8K | 65,000 | — | ↗ |
| 2020-08-25 | Ballaron Craig | Director | P-Purchase | A | Common Stock | 4,772 | 8.57 | 40.9K | 10,000 | — | ↗ |
| 2020-08-24 | Ballaron Craig | Director | P-Purchase | A | Common Stock | 5,228 | 9.16 | 47.9K | 5,228 | — | ↗ |
| 2020-08-20 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 20,000 | 9.09 | 181.8K | 8,099,394 | — | ↗ |
| 2020-08-18 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 8.55 | 85.5K | 1,481,719 | — | ↗ |
| 2020-08-17 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 6,000 | 6.92 | 41.5K | 1,471,719 | — | ↗ |
| 2020-08-14 | Stalfort Sean | Director | P-Purchase | A | Common Stock | 15,700 | 6.38 | 100.2K | 462,110 | — | ↗ |
| 2020-08-14 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 6.51 | 325.5K | 1,465,719 | — | ↗ |
| 2020-08-13 | White Ted | Director / Officer | P-Purchase | A | Common Stock | 10,661 | 6.28 | 67.0K | 17,966 | — | ↗ |
| 2020-08-13 | Stalfort Sean | Director | P-Purchase | A | Common Stock | 15,550 | 6.45 | 100.3K | 446,410 | — | ↗ |
| 2020-08-13 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 108,500 | 6.41 | 695.5K | 1,415,719 | — | ↗ |
| 2020-08-13 | DAVIS A BRIAN | Officer | P-Purchase | A | Common Stock | 7,900 | 6.24 | 49.3K | 7,900 | — | ↗ |
| 2020-08-01 | Goldenberg Gary | Officer | A-Award | A | Employee Stock Option (right to buy) | 250,000 | 6.56 | 1.64M | 250,000 | — | ↗ |
| 2020-08-01 | Eichenfield Lawrence | Director | A-Award | A | Stock Option (right to buy) | 17,502 | 6.56 | 114.8K | 17,502 | — | ↗ |
| 2020-06-11 | PRYGOCKI MARK A SR | Director | A-Award | A | Option Grant (right to buy) | 5,834 | 11.38 | 66.4K | 5,834 | — | ↗ |
| 2020-06-11 | Goldenberg Gary | Director | A-Award | A | Option Grant (right to buy) | 5,834 | 11.38 | 66.4K | 5,834 | — | ↗ |
| 2020-06-11 | Ballaron Craig | Director | A-Award | A | Option Grant (right to buy) | 5,834 | 11.38 | 66.4K | 5,834 | — | ↗ |
| 2020-06-09 | Nguyen Diem | Director | A-Award | A | Stock Option (right to buy) | 17,502 | 12.64 | 221.2K | 17,502 | — | ↗ |
| 2020-02-27 | White Ted | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 125,000 | 11.81 | 1.48M | 125,000 | — | ↗ |
| 2020-02-27 | Hayes Christopher G. | Officer | — | D | Employee Stock Option (Right to Buy) | 58,343 | 16.32 | 952.2K | 0 | — | ↗ |
| 2020-02-27 | DAVIS A BRIAN | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 55,000 | 11.81 | 649.6K | 55,000 | — | ↗ |
| 2020-02-27 | Burnett Patrick | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 55,000 | 11.81 | 649.6K | 55,000 | — | ↗ |
| 2020-02-27 | Bonaccorso Joe | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 55,000 | 11.81 | 649.6K | 55,000 | — | ↗ |
| 2019-10-18 | DAVIS A BRIAN | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 14.65 | 1.83M | 125,000 | — | ↗ |
| 2019-10-10 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 6,900 | 15.05 | 103.8K | 8,079,394 | — | ↗ |
| 2019-10-09 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 8,778 | 14.06 | 123.4K | 8,072,494 | — | ↗ |
| 2019-10-08 | Manning Paul B | Director / 10% Owner | P-Purchase | A | Common Stock | 5,208 | 14.02 | 73.0K | 8,063,716 | — | ↗ |
| 2019-09-09 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 6,300 | 10.82 | 68.2K | 2,556,179 | — | ↗ |
| 2019-09-06 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,400 | 12.07 | 16.9K | 2,562,479 | — | ↗ |
| 2019-09-05 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 3,100 | 10.29 | 31.9K | 2,572,393 | — | ↗ |
| 2019-08-29 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 2,188 | 10.14 | 22.2K | 2,575,493 | — | ↗ |
| 2019-08-27 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 500 | 10.23 | 5.1K | 2,577,681 | — | ↗ |
| 2019-08-09 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 2,773 | 10.21 | 28.3K | 2,578,181 | — | ↗ |
| 2019-08-08 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 3,118 | 10.76 | 33.5K | 2,580,954 | — | ↗ |
| 2019-08-07 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 422 | 10.28 | 4.3K | 2,584,072 | — | ↗ |
| 2019-08-06 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 2,602 | 10.28 | 26.7K | 2,584,494 | — | ↗ |
| 2019-08-05 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,679 | 10.65 | 17.9K | 2,587,096 | — | ↗ |
| 2019-08-02 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,969 | 10.78 | 21.2K | 2,588,775 | — | ↗ |
| 2019-08-01 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,953 | 11.97 | 23.4K | 2,590,744 | — | ↗ |
| 2019-07-31 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 3,500 | 12.02 | 42.1K | 2,592,697 | — | ↗ |
| 2019-07-30 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 4,885 | 11.83 | 57.8K | 2,596,197 | — | ↗ |
| 2019-07-29 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 630 | 12.52 | 7.9K | 2,601,082 | — | ↗ |
| 2019-07-26 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,902 | 10.65 | 20.3K | 2,610,263 | — | ↗ |
| 2019-07-25 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 975 | 10.23 | 10.0K | 2,612,165 | — | ↗ |
| 2019-07-24 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 502 | 10.19 | 5.1K | 2,613,140 | — | ↗ |
| 2019-07-23 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,600 | 10.28 | 16.4K | 2,613,642 | — | ↗ |
| 2019-07-22 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 700 | 10.17 | 7.1K | 2,615,242 | — | ↗ |
| 2019-07-19 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,800 | 10.28 | 18.5K | 2,615,942 | — | ↗ |
| 2019-07-18 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 6,700 | 10.27 | 68.8K | 2,617,742 | — | ↗ |
| 2019-07-17 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 2,300 | 10.55 | 24.3K | 2,624,442 | — | ↗ |
| 2019-07-16 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 2,200 | 10.92 | 24.0K | 2,626,742 | — | ↗ |
| 2019-07-15 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 5,290 | 10.89 | 57.6K | 2,628,942 | — | ↗ |
| 2019-07-12 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 3,000 | 11.01 | 33.0K | 2,634,232 | — | ↗ |
| 2019-07-11 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,640 | 11.16 | 18.3K | 2,637,232 | — | ↗ |
| 2019-07-10 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 9,105 | 11.57 | 105.3K | 2,638,872 | — | ↗ |
| 2019-07-09 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 2,467 | 11.88 | 29.3K | 2,647,977 | — | ↗ |
| 2019-07-08 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 5,675 | 11.06 | 62.8K | 2,650,444 | — | ↗ |
| 2019-07-05 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 3,954 | 11.41 | 45.1K | 2,656,119 | — | ↗ |
| 2019-07-03 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 2,900 | 11.50 | 33.4K | 2,660,073 | — | ↗ |
| 2019-07-02 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 6,239 | 11.57 | 72.2K | 2,662,973 | — | ↗ |
| 2019-07-01 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 15,421 | 12.00 | 185.1K | 2,669,212 | — | ↗ |
| 2019-06-28 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 3,502 | 10.63 | 37.2K | 2,692,992 | — | ↗ |
| 2019-06-25 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 210 | 10.04 | 2.1K | 2,696,494 | — | ↗ |
| 2019-06-13 | Davidson Matt | 10% Owner | S-Sale | D | Common Stock | 1,431 | 10.03 | 14.4K | 2,696,704 | — | ↗ |
| 2019-06-13 | Ballaron Craig | Director | A-Award | A | Stock Option (Right to Buy) | 17,502 | 9.87 | 172.7K | 17,502 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-157.1K
Shares Outstanding
10.65M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Christopher G. Hayes Former Chief Legal Officer | 155.3K | — | — | 100.3K | 10.0K | 481.9K | 747.6K | 13.42% | ↗ |
| 2 | 2025 | Jayson Rieger President and Chief Executive Officer | 300.0K | — | — | 350.2K | 74.4K | 16.8K | 741.4K | 47.24% | ↗ |
| 3 | 2025 | John J. Kirby Interim Chief Financial Officer | 480.0K | 10.0K | 82.1K | — | 42.5K | — | 614.6K | 13.36% | ↗ |
| 4 | 2025 | Gary Goldenberg Former Chief Medical Officer | 79.1K | — | — | 48.0K | — | 236.1K | 363.1K | 13.22% | ↗ |
| 5 | 2025 | Noah Rosenberg Chief Medical Officer | 173.9K | 25.0K | — | 139.0K | — | 9.7K | 347.6K | 40.00% | ↗ |
| 6 | 2024 | Ted White Former President and Chief Executive Officer | 527.6K | — | 540.0K | 855.9K | — | 670.8K | 2.59M | 53.80% | ↗ |
| 7 | 2024 | Joe Bonaccorso Former Chief Commercial Officer | 307.8K | — | 192.0K | 304.3K | — | 474.9K | 1.28M | 38.80% | ↗ |
| 8 | 2024 | Jayson Rieger President and Chief Executive Officer | 47.7K | — | — | 1.19M | — | 754.00 | 1.24M | 96.08% | ↗ |
| 9 | 2024 | Christopher G. Hayes Chief Legal Officer | 466.0K | — | 192.0K | 354.7K | — | 15.3K | 1.03M | 53.18% | ↗ |
| 10 | 2024 | Christopher G. Hayes Former Chief Legal Officer | 466.0K | — | 192.0K | 354.7K | — | 15.3K | 1.03M | 53.18% | ↗ |
| 11 | 2024 | Gary Goldenberg Former Chief Medical Officer | 462.8K | — | 192.0K | 304.3K | — | 14.2K | 973.3K | 50.99% | ↗ |
| 12 | 2024 | John J. Kirby Interim Chief Financial Officer | 73.3K | — | 40.5K | — | — | — | 114.6K | 35.34% | ↗ |
| 13 | 2023 | Ted White Former President and Chief Executive Officer | 600.6K | — | 1.14M | 1.45M | 300.3K | 13.8K | 3.50M | 73.90% | ↗ |
| 14 | 2023 | Ted White President, Chief Executive Officer and Director | 600.6K | — | 1.14M | 1.45M | 300.3K | 13.8K | 3.50M | 73.90% | ↗ |
| 15 | 2023 | Christopher G. Hayes Chief Legal Officer | 424.0K | — | 1.14M | 817.9K | 169.6K | 13.8K | 2.56M | 76.31% | ↗ |
| 16 | 2023 | Joe Bonaccorso Former Chief Commercial Officer | 444.0K | — | 947.5K | 514.6K | 177.6K | 13.8K | 2.10M | 69.71% | ↗ |
| 17 | 2023 | Joe Bonaccorso Chief Commercial Officer | 444.0K | — | 947.5K | 514.6K | 177.6K | 13.8K | 2.10M | 69.71% | ↗ |
| 18 | 2022 | Ted White President, Chief Executive Officer and Director | 572.0K | — | — | 1.16M | 185.9K | 14.9K | 1.94M | 60.08% | ↗ |
| 19 | 2022 | Gary Goldenberg Chief Medical Officer | 426.4K | — | — | 436.1K | 110.9K | 15.8K | 989.2K | 44.09% | ↗ |
| 20 | 2022 | Joe Bonaccorso Chief Commercial Officer | 425.0K | — | — | 436.1K | 110.5K | 14.9K | 986.5K | 44.21% | ↗ |
| 21 | 2021 | Ted White President, Chief Executive Officer and Director | 550.0K | — | — | 1.68M | 206.3K | 41.4K | 2.48M | 67.81% | ↗ |
| 22 | 2021 | Gary Goldenberg Chief Medical Officer | 410.0K | — | — | 682.5K | 123.0K | 39.8K | 1.26M | 54.37% | ↗ |
| 23 | 2021 | Joe Bonaccorso Chief Commercial Officer | 408.8K | — | — | 682.5K | 122.6K | 10.4K | 1.22M | 55.74% | ↗ |
| 24 | 2020 | Ted White President, Chief Executive Officer and Director | 485.0K | — | — | 980.9K | 194.0K | 46.8K | 1.71M | 57.47% | ↗ |
| 25 | 2020 | Gary Goldenberg Chief Medical Officer | 175.6K | 60.0K | — | 1.16M | 53.3K | 62.9K | 1.51M | 76.77% | ↗ |
| 26 | 2020 | A. Brian Davis Chief Financial Officer | 388.1K | — | — | 431.6K | 124.2K | 63.8K | 1.01M | 42.83% | ↗ |
| 27 | 2019 | Ted White President, Chief Executive Officer and Director | 433.3K | — | — | 775.0K | 198.0K | 34.9K | 1.44M | 53.78% | ↗ |
| 28 | 2019 | A. Brian Davis Chief Financial Officer | 76.9K | — | — | 1.23M | 30.8K | 4.3K | 1.34M | 91.63% | ↗ |
| 29 | 2019 | Joe Bonaccorso Chief Commercial Officer | 370.4K | — | — | 474.8K | 149.8K | 7.9K | 1.02M | 46.65% | ↗ |
| 30 | 2018 | Ted White, President Chief Executive Officer and Director | 400.0K | — | — | 4.37M | 225.0K | 5.6K | 5.00M | 87.38% | ↗ |
| 31 | 2018 | Ted White President, Chief Executive Officer and Director | 400.0K | — | — | 4.37M | 225.0K | 5.6K | 5.00M | 87.38% | ↗ |
| 32 | 2018 | Linda Palczuk Former Chief Operating Officer | 295.7K | — | — | 684.9K | 149.2K | 712.00 | 1.13M | 60.58% | ↗ |
| 33 | 2018 | Joe Bonaccorso Chief Commercial Officer | 315.7K | — | — | 617.7K | 158.3K | 5.6K | 1.10M | 56.29% | ↗ |
| 34 | 2017 | Ted White, President Chief Executive Officer and Director | 24.4K | — | — | — | — | — | 24.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chris Chapman | Chief Commercial Officer | 635.4K | male |
| John J. Kirby | Interim Chief Financial Officer | 532.5K | male |
| Jayson Rieger | President, Chief Executive Officer & Director | 391.2K | — |
| Noah L. Rosenberg | Chief Medical Officer | 243.3K | — |
| Eugene Scavola | Executive Vice President of Technical Operations | — | male |
| David Zawitz | COO, Chief Legal Officer & Secretary | — | male |
| Bradley J. Catalone | Head of Drug Development | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VRCA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
